<ѻýҕl>No-Implant Shunt Eases HF Symptoms in Early Dataѻýҕl> Quality of life consistently improved across first-in-man studies May 20, 2022
<ѻýҕl>TAVR Stays Its Course as 10-Year Durability Data Trickle Inѻýҕl> Glimpse of longer-term valve degeneration in early TAVR patients May 19, 2022
<ѻýҕl>Even With CKD, Patiromer Helped Heart Failure Patients Keep Hyperkalemia at Bayѻýҕl> Promising findings from prespecified renal analysis of the DIAMOND trial Apr 09, 2022
<ѻýҕl>Systemic Corticosteroids in Acute HF: Worth Another Look?ѻýҕl> Some see a potential treatment for patients with more inflammation Apr 08, 2022
<ѻýҕl>Patiromer Limits Impact of RAAS Inhibitor-Related Hyperkalemia in HFѻýҕl> Patients better able to achieve target dose of mineralocorticoids and angiotensin inhibitors Apr 04, 2022
<ѻýҕl>EHR Pop-Ups Spur Better GDMT Implementation in Heart Failureѻýҕl> Alert-based intervention in PROMPT-HF trial said to be low-cost, scalable Apr 03, 2022
<ѻýҕl>Low-Salt Diet Helpful for HF Symptoms, but Not Necessarily for Clinical Eventsѻýҕl> Sodium restriction still holds its ground in SODIUM-HF trial Apr 02, 2022
<ѻýҕl>From 'Pre-HF' to 'HFimpEF': Guidelines Redefine Heart Failure Stages, Classesѻýҕl> Update also adds SGLT2 inhibitor as a pillar of therapy Apr 01, 2022
<ѻýҕl>In HFpEF, Do MRA Users Get as Much Benefit From an SGLT2 Inhibitor?ѻýҕl> EMPEROR-Preserved trial weighs in Mar 21, 2022
<ѻýҕl>ARB-Cancer Link May Come Down to Cumulative Exposureѻýҕl> Does a new paper resolve the conflicting safety data on the popular antihypertensives? Mar 02, 2022
<ѻýҕl>Salt in Fizzy Tablets Linked to Heart, Death Riskѻýҕl> Warning signals seen for fast-acting acetaminophen and other drugs Feb 24, 2022
<ѻýҕl>A Simple Way to Tell When Asymptomatic Aortic Stenosis Isn't So Benignѻýҕl> Could regular NT-proBNP testing be of value to patients with non-severe AS? Feb 16, 2022
<ѻýҕl>ACIP Embraces Spikevax Amid Serious Talk of Changing mRNA Dosing Intervalѻýҕl> Would longer time between doses do the trick to reduce myocarditis risk? Feb 04, 2022
<ѻýҕl>Death During Sex: Not Just an Old Man Thingѻýҕl> But sudden cardiac death remains rare even for sexually active people with heart conditions Jan 12, 2022
<ѻýҕl>Hospitalized Acute HF Patients See Clinical Benefits With Empagliflozinѻýҕl> EMPULSE results support early start for the SGLT2 inhibitor, but more data needed, expert says Nov 16, 2021
<ѻýҕl>Peak VO2 Improved After Beta-Blocker Withdrawal in Some HFpEF Patientsѻýҕl> Beta-blockers may not benefit HFpEF patients with chronotropic incompetence Nov 15, 2021
<ѻýҕl>Delaying Surgery Hurts Patients With Silent Aortic Stenosisѻýҕl> Early aortic valve replacement wins in AVATAR trial Nov 13, 2021
<ѻýҕl>More Good News for Empagliflozin in Patients With Heart Failureѻýҕl> Slower renal function decline with SGLT-2 inhibitor in EMPEROR-Preserved trial Nov 06, 2021
<ѻýҕl>Longstanding Vascular Closure Technique Triumphs Over Collagen Plugѻýҕl> Manta versus ProGlide after transfemoral TAVR in CHOICE-CLOSURE Nov 06, 2021
<ѻýҕl>TAVR Operators Divided on Need for Bicuspid RCTѻýҕl> Odds of a study coming to fruition are low Nov 05, 2021
<ѻýҕl>Too Many TAVR Centers Are Clustered Around Well-to-Do Communitiesѻýҕl> More centers not the answer to geographic, socioeconomic disparities in access? Oct 22, 2021
<ѻýҕl>Study: Kids Exposed to Harmful Plastics During Heart Surgeryѻýҕl> Are tubing and blood bags sources of trouble? Oct 09, 2021
<ѻýҕl>Post-TAVR Pacemakers Not All Doom and Gloomѻýҕl> A bit of reassurance from Swedish cohort study Oct 04, 2021
<ѻýҕl>Low Risk and Bicuspid Anatomy: A Passable Combination for TAVR Thus Farѻýҕl> Clinical outcomes not worse compared with tricuspid TAVR Sep 21, 2021
<ѻýҕl>With HVAD Out, Innovation Key to Mechanical Circulatory Supportѻýҕl> A debate on where LVAD innovation stands Sep 14, 2021
<ѻýҕl>Transplant Docs Are Sticking With Invasive Biopsies After Heart Transplantsѻýҕl> Agreement that non-invasive alternatives to EMB are not ready for routine rejection surveillance Sep 13, 2021
<ѻýҕl>SGLT2 Inhibitor Eases Symptoms for HFpEF Patientsѻýҕl> Trial suggests hard outcomes not the only ones helped by this class of medication Sep 13, 2021
<ѻýҕl>Second-Gen Drug for HCM Emerges, Nipping at Mavacamten's Heelsѻýҕl> Novel cardiac myosin inhibitor is headed for a phase III trial Sep 12, 2021
<ѻýҕl>Heart Failure's 'Golden Moment' Not Translating into Better Healthѻýҕl> Problems of implementation and health equity persist Sep 12, 2021
<ѻýҕl>Feared ARNI Effect on Cognition Hasn't Come to Fruitionѻýҕl> Neurocognitive protection by sacubitril/valsartan suggested instead by observational study Sep 12, 2021
<ѻýҕl>Good Results When Giving Flu Shots to MI Survivors Still in the Hospitalѻýҕl> Vaccination prior to discharge linked to heart benefit Aug 30, 2021
<ѻýҕl>Polypills Ready for Prime Time in Large Swaths of People, Researchers Sayѻýҕl> Question now is how to implement fixed-dose combo therapy in clinical practice Aug 29, 2021
<ѻýҕl>His Bundle Pacing Stars in European Guidelinesѻýҕl> Revised edition could signal coming U.S. recommendations too Aug 29, 2021
<ѻýҕl>Ablation, CRT Boost Survival in Permanent Afib With Narrow QRSѻýҕl> APAF-CRT trial reinforces the case for expanded CRT indication Aug 28, 2021
<ѻýҕl>Revamped Valve Disease Guideline: Europe Sees Nearly Eye to Eye With U.S.ѻýҕl> There is a different approach to deciding the suitability of TAVR, however Aug 28, 2021
<ѻýҕl>A Familiar Drug Can Keep Early-Stage HCM at Bayѻýҕl> Treatment with valsartan most beneficial when started early? Aug 27, 2021
<ѻýҕl>Empagliflozin Improves Outcomes in HFpEF Patientsѻýҕl> "A major win" for heart failure with preserved ejection fraction, says editorialist Aug 27, 2021
<ѻýҕl>New Heart Failure Guidelines Released, but Are They Already Out of Date?ѻýҕl> Results of EMPEROR-Preserved contradict guidance Aug 27, 2021
<ѻýҕl>Milder Heart Failure Might Benefit From Implantable Monitorsѻýҕl> Randomized trial signals benefit, albeit hampered by the pandemic Aug 27, 2021
<ѻýҕl>Deadly Arrhythmias Less of a Risk for HF Patients on Dapagliflozinѻýҕl> DAPA-HF analysis further explores mechanism of SGLT2 inhibitor's heart benefits Aug 27, 2021